decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 9 (September)
New Zometa policy from Aetna
Subscribe or sign in to view the full article.
Article Overview
This short article reviews a new Aetna policy bulletin for Zometa (zoledronic acid), a medication used in oncology-related care. It explains the policy’s effective date, the broad conditions addressed in the coverage bulletin, and the general coding references mentioned for billing and diagnosis reporting. The piece is useful for coders, billers, and reimbursement staff who need to know whether the policy is relevant to oncology infusion claims and related medical necessity review.
Why This Topic Matters
Payer policy updates can affect whether services are considered covered and how claims are documented. This article helps readers identify the relevant policy, specialty area, and code sets referenced in the bulletin before reviewing the full policy text.
What You Will Learn
- The scope of an Aetna policy bulletin involving Zometa.
- Which general oncology-related conditions are addressed in the bulletin.
- Which code sets are referenced for billing and diagnosis reporting.
- The effective date and policy bulletin reference mentioned in the article.
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Oncology practices
- Prior authorization teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com